JP2003062068A - Needle cannula for injection of liquid medicine and syringe equipped therewith - Google Patents

Needle cannula for injection of liquid medicine and syringe equipped therewith

Info

Publication number
JP2003062068A
JP2003062068A JP2001253880A JP2001253880A JP2003062068A JP 2003062068 A JP2003062068 A JP 2003062068A JP 2001253880 A JP2001253880 A JP 2001253880A JP 2001253880 A JP2001253880 A JP 2001253880A JP 2003062068 A JP2003062068 A JP 2003062068A
Authority
JP
Japan
Prior art keywords
needle tube
drug solution
injecting
injection
curved shape
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001253880A
Other languages
Japanese (ja)
Other versions
JP4892800B2 (en
Inventor
Yasuhiro Shimizu
康広 清水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JMS Co Ltd
Original Assignee
JMS Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JMS Co Ltd filed Critical JMS Co Ltd
Priority to JP2001253880A priority Critical patent/JP4892800B2/en
Publication of JP2003062068A publication Critical patent/JP2003062068A/en
Application granted granted Critical
Publication of JP4892800B2 publication Critical patent/JP4892800B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
    • A61M5/3291Shafts with additional lateral openings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M2005/341Constructions for connecting the needle, e.g. to syringe nozzle or needle hub angularly adjustable or angled away from the axis of the injector

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a needle cannula for the injection of liquid medicine such as anesthetic solution to relieve a pain in an introversion method to be used in the removal of veins in the large saphenous vein (LSV) and small saphenous vein (SSV) and not limited to that, during and after accompanying a strip procedure in conventional stripping operations, a hemostatic solution and the like capable of injecting them effectively and easily along the LSV and SSV. SOLUTION: The needle cannula for the injection of liquid medicine comprises the following features: 1. a curved shape is previously formed, and the needle cannula has at least a small opening for the injection of pharmaceutical solution at the leading edge portion, and the leading edge portion has a round structure so as not to puncture living tissues. 2. It has such flexibility to allow a curved formation by the use of a human hand and has at least a small opening for the injection of pharmaceutical solution at the leading edge portion. Further, it has a round structure at the leading edge portion so as not to puncture living tissues.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明が属する技術分野】本発明は、薬液注入用針管、
特に大伏在静脈(LSV)あるいは小伏在静脈(SS
V)の静脈瘤の除去手術の際に、大伏在静脈(LSV)
あるいは小伏在静脈(SSV)に沿って挿入および移動
させ、その周囲に麻酔液のよう薬液を注入するために使
用する長大、例えば長さ20cm以上の薬液注入用針管
に関する。
TECHNICAL FIELD The present invention relates to a needle tube for injecting a drug solution,
Especially great saphenous vein (LSV) or small saphenous vein (SS
V) during surgery to remove varicose veins, great saphenous vein (LSV)
Alternatively, the present invention relates to a long needle, for example, a needle tube for injecting a drug solution having a length of 20 cm or more, which is used for inserting and moving along a small saphenous vein (SSV) and injecting a drug solution such as an anesthetic solution around the vein.

【0002】[0002]

【従来の技術】伏在静脈瘤に対する治療法は、静脈結紮
術併用硬化療法と、従来のストリッピング手術(静脈抜
去術)が広く行われている。前者は低襲性で外来手術が
可能であるが、大腿部穿通枝を介しての再発が多く見ら
れるなど根治性に問題がある。後者の根治性は高いが、
低襲性が大きく短期滞在手術としては無理がある。本発
明者らは、高い根治性と低襲性を両立させる術式とし
て、内翻法による選択的静脈抜術、特にLSVに対する
選択的静脈抜術法に好適に使用される内翻用ストリッパ
ーを先に提案している。
2. Description of the Related Art As a treatment method for saphenous varices, sclerotherapy combined with vein ligation and conventional stripping surgery (vein extraction) are widely used. The former is less invasive and allows outpatient surgery, but has a problem of curability, such as frequent recurrence via the femoral perforator. The latter is highly curable,
It is extremely low-invasive and is not possible as a short-term operation. The present inventors have proposed a stripping tool for inversion, which is preferably used for a selective vein removal operation by an internalization method, in particular, a selective vein removal method for LSV, as a surgical method that achieves both high curability and low aggression. I have proposed it earlier.

【0003】[0003]

【発明が解決しようとする課題】本発明は、大伏在静脈
(LSV)および小伏在静脈(SSV)の静脈除去に使
用される内翻法、およびそれらのみならず、従来のスト
リッピング手術における静脈抜去に伴う術中および術後
の疼痛を軽減するための麻酔液、止血液等の薬液を効果
的かつ簡単にLSVおよびSSVに沿って注入できる薬
液注入針管を提供することにある。さらに、本発明は、
LSVおよびSSVの周囲に低濃度の大量局所湿潤麻酔
(TLA)を行うことのできる薬液注入用針管を提供す
ることにある。ただし、本発明の薬液注入針管は、前記
の内翻式静脈瘤除去手術法の使用に限定されるものでは
なく、他の手術、たとえば形成外科で行われる過多の脂
肪酸吸引のような手術にも適用可能である。
SUMMARY OF THE INVENTION The present invention is directed to the internal reversal method used for vein removal of the great saphenous vein (LSV) and small saphenous vein (SSV), as well as conventional stripping surgery. To provide a drug solution injection needle tube capable of effectively and easily injecting a drug solution such as an anesthetic solution or hemostasis for reducing pain during and after the operation associated with vein removal in LSV and SSV. Further, the present invention provides
It is an object of the present invention to provide a needle tube for injecting a medicinal solution capable of performing high-concentration local hyperanemic anesthesia (TLA) at low concentration around LSV and SSV. However, the drug solution injection needle tube of the present invention is not limited to the use of the inversion varicose vein removal surgical method described above, and is applicable to other operations such as surgery such as excessive fatty acid suction performed in plastic surgery. Applicable.

【0004】[0004]

【課題を解決するための手段】本発明は、針管が湾曲形
状にあらかじめ形成され、少なくとも先端側部分に薬液
注入用の小孔を有し、かつ先端部が生体組織を穿刺しな
い丸みを帯びた構造であることを特徴とする薬液注入用
針管、あるいは人手によって針管を湾曲形状に形成する
ことが可能な可撓性を有し、また、少なくとも先端側部
分に薬液注入用の小孔を有し、かつ先端部が生体組織を
穿刺しない丸みを帯びた構造であることを特徴とする薬
液注入用針管を提供することにより、前記課題を解決す
ることができた。本発明の薬液注入用針管は、上述のよ
うに血管等の人体組織を穿刺しないように、その先端部
が生体組織を穿刺しない丸みを帯びた構造であるので、
該針管を生体組織内に挿入する場合、挿入箇所を別の切
開器具で切開した後に使用される。また、前記の湾曲形
状は、薬液注入用針管を生体組織内に挿入し易くし、さ
らには生体組織内を移動し易くする機能を有し、かつ該
薬液注入用針管を生体組織内に挿入および移動させる際
に生体組織を穿刺したり、傷つけたりしない程度の曲率
半径(アール)を有する形状のものを言う。特に前記湾
曲形状は、図1に示すように針管全体が均一な曲率を有
する湾曲形状であり、かつその湾曲度がなだらかなこと
が、前記の機能を奏する上で特に好ましい。具体的な曲
率半径としては、650〜850アール程度、より好ま
しくは700〜780アール程度である。ただし、該湾
曲形状あるいは湾曲度は、本発明の薬液注入用針管の生
体組織に対する使用個所に応じて適宜好ましいものが選
択されるものであって、特定の範囲のものに限定される
ものではない。
According to the present invention, a needle tube is formed in advance in a curved shape, has a small hole for injecting a drug solution at least at a tip side portion, and has a rounded tip end portion that does not puncture living tissue. A needle tube for injecting a liquid medicine characterized by having a structure, or flexibility capable of manually forming the needle tube into a curved shape, and having a small hole for injecting a liquid medicine at least at the tip side portion. The problem can be solved by providing a medicinal solution injection needle tube having a rounded structure in which the distal end portion does not puncture a biological tissue. The drug solution injection needle tube of the present invention has a rounded structure whose tip does not puncture biological tissue so as not to puncture human tissues such as blood vessels as described above.
When inserting the needle tube into the living tissue, it is used after the insertion site is incised with another incision instrument. Further, the curved shape has the function of facilitating insertion of the drug solution injection needle tube into the living tissue, and further having the function of facilitating movement within the body tissue, and inserting the drug solution injection needle tube into the living tissue and It is a shape having a radius of curvature (R) that does not puncture or damage the living tissue when it is moved. In particular, the curved shape is a curved shape in which the entire needle tube has a uniform curvature as shown in FIG. 1, and it is particularly preferable that the degree of curvature is gentle in order to achieve the above-mentioned function. The specific radius of curvature is about 650 to 850 ares, and more preferably about 700 to 780 ares. However, the curved shape or the degree of curvature is appropriately selected according to the location where the drug solution injection needle tube of the present invention is used for living tissue, and is not limited to a specific range. .

【0005】本発明の薬液注入用針管の前記湾曲形状
は、生体内への挿入および移動によってもその湾曲形状
を保持することのできる剛性を有することが好ましい。
また、前記湾曲部は、図2に示すような湾曲をしていな
い針管を、上述のように人手によって施術前に形成し、
その形状を施術箇所、あるいは施術箇所の大きさ、ある
いは形状に応じて形成することができる。ただし、前記
湾曲形状は該薬液注入用針管の製造、あるいは販売者に
よってあらかじめ形成されたものであっても良い。前記
のような種々の特性を満足するために、本発明の薬液注
入用針管を構成する基材として、該基材の少なくとも一
部が銅材料で構成されることが好ましい。
It is preferable that the curved shape of the drug solution injecting needle tube of the present invention has rigidity so that the curved shape can be maintained even when the needle tube is inserted and moved in the living body.
Further, the bending portion is formed by manually forming a needle tube which is not curved as shown in FIG. 2 before the operation as described above,
The shape can be formed according to the treatment site, or the size or shape of the treatment site. However, the curved shape may be formed in advance by the manufacturer or the seller of the drug solution injection needle tube. In order to satisfy the above-mentioned various characteristics, it is preferable that at least a part of the base material is made of a copper material as the base material that constitutes the drug solution injection needle tube of the present invention.

【0006】[0006]

【発明の実施の態様】本発明の薬液注入用針管の湾曲形
状は、切開部から針管を生体内に挿入し、LSV、SS
Vに沿って配置したときに、針管の操作(移動やシリン
ジ等との接続など)がし易くなるように曲がっているの
が望ましい。例えば、針管の1/3以上をLSV、SS
Vに沿って配置したとき、針管基端側が切開部またはそ
の近傍の皮膚から浮き上がっていると、前記操作が容易
になる。直線状の針管では、前記血管に挿入した場合
に、針管基端側が皮膚面に接触し、針管基端部を皮膚か
ら離すと、血管に沿って配置された針管先端側が移動し
てしまう恐れがある。
BEST MODE FOR CARRYING OUT THE INVENTION The curved shape of the drug solution injection needle tube of the present invention has a LSV, SS
It is desirable that the needle tube is bent so that it can be easily operated (moved, connected to a syringe or the like) when arranged along V. For example, 1/3 or more of the needle tube is LSV, SS
When the needle tube proximal end side is lifted from the skin at or near the incision when placed along V, the above operation becomes easy. In a straight needle tube, when inserted into the blood vessel, the needle tube proximal end side comes into contact with the skin surface, and when the needle tube proximal end portion is separated from the skin, the needle tube distal end side arranged along the blood vessel may move. is there.

【0007】本発明の薬液注入用針管の直径は、本発明
の目的を達成できる範囲のものであれば特に限定される
ものではないが、12〜18ゲージのものが好ましく、
特に14〜16ゲージのものがより好ましい。針管の直
径が12ゲージ未満では多量の薬液を一度に注入してし
まい、また、18ゲージを超えると薬液を生体組織内に
注入する際に注入抵抗が大きくなり、必要な薬液量を注
入するのが困難になる。また、本発明の薬液注入用針管
の湾曲部を形成する前の長さも、施術箇所に応じて、本
発明の目的を達成できるように長大のものであれば特に
限定されるものではないが、一つの薬液注入用針管をL
SVおよびSSVの両者に共通に使用可能であるため
に、20cm程度以上のものが好ましい。本発明の薬液
注入針管の針管には、図1および2に示すように、針基
部分6が装着される。該針基部分としては、該部分内に
注射器の雄ルアーと連結可能なように雌ルアーがされて
いることが好ましく、さらに、前記雌ルアーは雄ルアー
が連結し易いようにテーパー部分を有して構成されてい
ることが好ましい。
The diameter of the drug solution injection needle tube of the present invention is not particularly limited as long as it can achieve the object of the present invention, but is preferably 12 to 18 gauge.
Particularly, those having 14 to 16 gauge are more preferable. If the diameter of the needle tube is less than 12 gauge, a large amount of the medicinal solution is injected at one time, and if it exceeds 18 gauge, the injection resistance becomes large when the medicinal solution is injected into the living tissue, and the necessary amount of the medicinal solution is injected. Becomes difficult. Further, the length before forming the curved portion of the drug solution injecting needle tube of the present invention is also not particularly limited as long as it is long so as to achieve the object of the present invention, depending on the site to be treated, One needle tube for chemical injection is L
Since it can be commonly used for both SV and SSV, it is preferably about 20 cm or more. As shown in FIGS. 1 and 2, a needle base portion 6 is attached to the needle tube of the liquid medicine injection needle tube of the present invention. As the needle base portion, it is preferable that a female luer is formed in the portion so that it can be connected to a male luer of a syringe. Further, the female luer has a tapered portion so that the male lure can be easily connected. It is preferable that

【0008】本発明の薬液注入針管は、少なくとも針管
先端側部分の管壁に、該針管内の薬液をその周囲の人体
組織に注入するために少なくとも一個の小孔を形成した
ものが好ましい。該小孔の数は1個、あるいは複数個で
あっても良いが、小孔の数が多すぎると、目的とする部
位だけに液を注入するのが困難となり、多く形成した孔
から、目的以外の部位に薬液が洩れ出て、効率が悪くな
る。一度に大量の溶液を人体組織、例えばLSVあるい
はSSVの周囲に均等に浸潤させることができない。し
たがって、前記小孔の数は1〜3個程度が好ましい。小
孔の数が3個以上になると一度に薬液を生体組織内に注
入することになり、目的とする生体組織の個所に、効率
的に薬液を湿潤させにくくなる。前記小孔の数が複数個
の場合、針管の側壁に設ける複数の孔の位置について
は、側壁の一方側のみに形成しても良いが、異なる側
壁、特に対向する側壁に交互に形成したものが、効率的
に薬液を湿潤させることができる、という観点からも好
ましい。また、前記小孔のすべてが先端部から35mm
以内に形成されていることが、薬液を無駄なく生体組織
に注入することができるので好ましい。さらに、前記針
管先端部は、丸みを帯びた構造としやすいので、小孔を
有しない閉塞構造であることが好ましい。
The drug solution injection needle tube of the present invention is preferably one in which at least one small hole is formed in at least the tube wall at the tip side portion of the needle tube for injecting the drug solution in the needle tube into the human tissue around it. The number of the small holes may be one or more, but if the number of the small holes is too large, it becomes difficult to inject the liquid only into the target site, and the holes formed with a large number may be used. The chemical solution leaks to other parts, resulting in poor efficiency. It is not possible to evenly infiltrate large amounts of solution at one time around human tissue, such as LSV or SSV. Therefore, the number of the small holes is preferably about 1 to 3. When the number of small holes is 3 or more, the drug solution is injected into the living tissue at one time, and it becomes difficult to efficiently wet the drug solution to the target site of the living tissue. When the number of the small holes is plural, the positions of the plural holes provided in the side wall of the needle tube may be formed only on one side of the side wall, but they are formed alternately on different side walls, particularly opposite side walls. However, it is preferable from the viewpoint that the chemical can be efficiently moistened. Also, all the small holes are 35 mm from the tip.
It is preferable to be formed within the range because the liquid medicine can be injected into the living tissue without waste. Furthermore, since the tip portion of the needle tube is likely to have a rounded structure, it is preferable that it has a closed structure having no small holes.

【0009】本発明の薬液注入針管は、静脈瘤除去に使
用される内翻式ストリッピング手術、特にLSVおよび
SSVの静脈瘤除去の内翻式ストリッピング手術におけ
る、術中および術後の疼痛を軽減するための麻酔液、止
血液等の薬液を効果的かつ簡単にLSVおよびSSVに
沿って注入、たとえば、LSVおよびSSVの周囲に低
濃度の大量局所浸潤麻酔(Tumescent Loc
al Anesthesia:TLA)を行うことので
きる。また、本発明の薬液注入針管は、脂肪組織内に過
多に存在する脂肪の吸引にも使用できる。
The drug solution injection needle tube of the present invention reduces intraoperative and postoperative pain in the inversion stripping surgery used for varicose vein removal, particularly in LSV and SSV varicose vein removal inversion stripping surgery. Anesthesia solution, hemostasis, etc., for effective and easy injection along the LSV and SSV, for example, low concentration massive local infiltration anesthesia (Tumescent Loc) around the LSV and SSV.
al Anesthesia (TLA) can be performed. The drug solution injection needle tube of the present invention can also be used for suctioning fat that is excessively present in adipose tissue.

【0010】本発明の薬液注入針管は、注射器に装着可
能であり、例えばルアー接続により注射器に装着して使
用される。該注射器としては、通常の構造の注射器を用
いることができ、また、通常30〜50cc程度のもの
が用いられ、LSVの治療に使用する場合には50cc
程度、SSVの治療に使用する場合には30cc程度の
ものが好ましい。
The drug solution injection needle tube of the present invention can be attached to a syringe, and is used by being attached to a syringe by, for example, a luer connection. As the syringe, a syringe having an ordinary structure can be used, and a syringe having a size of about 30 to 50 cc is usually used, and 50 cc when used for treating LSV.
When used for treatment of SSV, about 30 cc is preferable.

【0011】[0011]

【実施例】実施例1 LSVに対する内翻式静脈瘤除去手術 患者が臥床後ただちにミダゾラム2.5〜5.0mgを
静注して入眠させ、患者を消毒し敷布を覆った後に、塩
酸ペチジン1mgを時間差静注する。鼠径部の皮膚切開
予定部に皮膚切開前に、エピネフリン添加1%メビバカ
インを浸潤させ、局所麻酔させる。前記両者の麻酔剤の
併用により手術は自発呼吸下に安全に施行可能である。
前記鼠径部を1.5〜2.0cmの皮膚切開により、L
SVを露出する。さらに、静脈瘤の抜去する直前に、術
中および術後の疼痛を軽減する局所麻酔手段として、さ
らにLSVの周囲には低濃度の大量局所浸潤麻酔(Tu
mescent Local Anesthesia:
TLA)を図1に示すような本発明の薬液注入用針管を
注射器に装着したものを用いて行った。
Example 1 Inversion varicose vein removal surgery for LSV Immediately after decubitus, midazolam 2.5 to 5.0 mg is intravenously infused to put the patient to sleep, and after disinfecting the patient and covering the bed, 1 mg of pethidine hydrochloride is given. For a time lag. Prior to skin incision, the planned incision in the groin area is infiltrated with 1% mebivacaine containing epinephrine and local anesthesia is performed. Surgery can be safely performed under spontaneous breathing by using both anesthetics in combination.
Make a skin incision of 1.5 to 2.0 cm in the groin area to make L
Expose the SV. Immediately before the removal of the varicose vein, as a local anesthesia means for reducing intraoperative and postoperative pain, a low-concentration massive local infiltration anesthesia (Tu) is further provided around the LSV.
mescent Local Anesthesia:
TLA) was carried out using a syringe equipped with the needle tube for injecting the drug solution of the present invention as shown in FIG.

【0012】すなわち、図1に示すに丸みを帯びた先頭
部1および針基部6も含めて全体がなだらかな湾曲形状
を有し、かつ、15Gの直径と20cmの長さを有する
先端部1が丸みを帯びた長い針管を、容量50ccの注
射器に装着したものを用いて、エピネフリン添加0.3
%キシロカイン(リドカイン)溶液をLSVに沿ってそ
の周囲組織に1肢あたり100ml前後を浸潤させた。
前記針管は、先端部が35mm以内の一方の側壁に小孔
2を1個、対向する側壁に小孔3および4の2個の合計
3個の小孔を有する。前記キシロカイン溶液の浸潤によ
り、組織は膨張して"水浸し"になり、皮膚は血管収縮に
より蒼白となる。このTLA法の採用により静脈抜去時
の出血および疼痛による体動は軽減するのみならず、大
量の生理的食塩水の浸潤により静脈と周囲組織との剥離
が容易となり,静脈抜去はスムーズに行える。また、前
記のTLA法による鎮痛作用は術中,術当日,翌日まで
持続し,鏡痛剤はほとんど必要としない。
That is, as shown in FIG. 1, the tip portion 1 having a rounded head portion 1 and a needle base portion 6 as a whole has a gentle curved shape, and has a diameter of 15 G and a length of 20 cm. Using a rounded long needle tube attached to a syringe with a capacity of 50 cc, add epinephrine 0.3
% Xylocaine (lidocaine) solution was infiltrated into the surrounding tissues along the LSV at around 100 ml per limb.
The needle tube has one small hole 2 on one side wall whose tip is within 35 mm, and two small holes 3 and 4 on the opposite side wall, that is, three small holes in total. The infiltration of the xylocaine solution causes the tissue to swell to "water soak" and the skin to become pale due to vasoconstriction. By adopting this TLA method, not only body movements due to bleeding and pain at the time of vein removal are reduced, but also infiltration of a large amount of physiological saline facilitates separation of the vein from surrounding tissues, and vein removal can be performed smoothly. Further, the analgesic action by the TLA method described above lasts during the operation, on the day of the operation, and on the next day, and almost no arthroscopic drug is required.

【0013】次に手術器具として、LSVに対する内翻
用ストリッパーを用いて静脈瘤の抜去を行った。LSV
に対する内翻用ストリッパーは,径2mm,長さ110
cmのステンレス製撚り線ワイヤーで、その中央部に静
脈断端が結紮固定できるように高さ1mmの突出部を1
0mm間隔で設けており、"静脈結紮部"としている。ワ
イヤーの両端は静脈に挿入しやすいような先端形状をし
ており、かつ、ベル型ヘッド(抜去頭)が装着できるよ
うになっている。
Next, a varicose vein was removed using an inversion stripper for LSV as a surgical instrument. LSV
The inversion stripper has a diameter of 2 mm and a length of 110
cm stainless steel stranded wire with a 1 mm high protruding part at the center so that the vein stump can be ligated and fixed.
They are provided at intervals of 0 mm and serve as "vein ligatures". Both ends of the wire have a tip shape that facilitates insertion into a vein, and a bell-shaped head (extraction head) can be attached.

【0014】前記皮膚切開によりLSVを露出し、分
枝、および副伏在静脈等を全て結紮切断し、それに引き
続いて前記のLSVに対する内翻用ストリッパーによ
り、以下のような内翻法による選択的ストリッピングを
行う。ストリッパーのワイヤーをLSVの中枢端から末
梢に向けて挿入してあらかじめマーキングしてある本幹
の瘤化の最下端部(多くは膝下部)に進行させ、ワイヤ
ーの先端部を触知する部位あるいは先端の突き上げによ
り皮膚が***した直上に小皮膚切開を加える。該皮膚切
開部から静脈を露出し結紮切断した後、静脈からワイヤ
ーを引き出す。ワイヤーをさらに末梢へ牽引してワイヤ
ー中央にある静脈結紮部に静脈中枢端を結紮固定し、ワ
イヤーを緩徐に中枢から末梢に向けて牽引しつつ静脈中
枢端を内翻させ、静脈は膝部切開創より抜去する。
The LSV is exposed by the skin incision, all branches and accessory saphenous veins are ligated and cut, and subsequently, by the inversion stripper for the LSV, the following inversion method is selectively performed. Perform stripping. Insert the wire of the stripper from the central end of the LSV toward the periphery and advance it to the pre-marked lowermost part of the aneurysm of the trunk (mostly below the knee), and touch the tip part of the wire or Make a small skin incision just above the skin where the tip was pushed up. After exposing the vein from the skin incision and ligating and cutting it, a wire is pulled out from the vein. Pull the wire further to the periphery and ligate and fix the central end of the vein to the venous ligation in the center of the wire.Slowly pull the wire from the center toward the periphery to invert the central end of the vein, and cut the vein into the knee. Remove from incision.

【0015】静脈に断裂がおこった場合は、ワイヤーを
そのまま末梢にさらに牽引し膝部切開創より断裂した静
脈を除去し、次に静脈末梢端を静脈結紮部に結紮固定し
直して、末梢から中枢への内翻式ストリッピングを行
う。末梢からのストリッピングでも断裂した場合は、径
12mmベル型のヘッド(抜去頭)を装着して、Bab
cock法で遺残静脈を抜去する。遺残静脈はワイヤー
に結紮固定できないが、静脈はスパズムをおこして縮小
しており、大きいサイズのヘッドを用いるため、ヘッド
部に団塊を形成して抜去可能である。
When the vein is torn, the wire is further pulled as it is to the periphery to remove the torn vein from the knee incision, and then the distal end of the vein is ligated and fixed to the vein ligation part again, Introvert stripping to the center. If it is ruptured even by stripping from the periphery, attach a bell-shaped head (extraction head) with a diameter of 12 mm and
The residual vein is removed by the Cock method. The residual vein cannot be ligated and fixed to the wire, but the vein causes spasm and contracts, and since a large-sized head is used, a nodule can be formed at the head portion and removed.

【0016】実施例2 SSVに対する内翻式静脈瘤除去手術 実施例1の内翻式静脈瘤除去手術において、皮膚切開を
膝下部に行い、また、エピネフリン添加0.3%キシロ
カイン(リドカイン)溶液の注入を、前記したような湾
曲部を有し、かつ、15Gの直径と15cmの長さを有
する先端部が丸みを帯びた長い針管を、容量30ccの
注射器に装着したものを用いて、エピネフリン添加0.
3%キシロカイン(リドカイン)溶液をSSVに沿って
その周囲組織に1肢あたり100ml前後を浸潤させ
た。前記針管は、先端部が35mm以内の一方の側壁に
1個、対向する側壁に2個の合計3個の小孔を有する。
Example 2 Inversion varicose vein removal surgery for SSV In the inversion varicose vein removal surgery of Example 1, a skin incision was made in the lower knee, and epinephrine-added 0.3% xylocaine (lidocaine) solution was used. For injection, epinephrine was added using a long needle tube having a curved portion as described above and having a diameter of 15 G and a length of 15 cm with a rounded tip, which was attached to a syringe with a capacity of 30 cc. 0.
A 3% xylocaine (lidocaine) solution was infiltrated into the surrounding tissues along SSV at around 100 ml per limb. The needle tube has a total of three small holes, one on one side wall with a distal end within 35 mm and two on the opposite side walls.

【0017】また、SSVに対する内翻用ストリッパー
としては、径2mm,長さ27mmの屈曲可能な銀メッ
キした銅棒に径1.2mm、長さ45cmのステンレス
ワイヤーを結合したもので、結合部よりワイヤー側に静
脈結紮部を設けている。前記ステンレス棒は静脈に挿入
し,末梢部で切開した皮膚から突き出すことができる。
また、前記ステンレスワイヤーの端にはBabcock
法に変更できるようにベル型ヘッド(抜去頭)が装着で
きるようになっている。SSVに対する内翻抜去は、実
施例1のLSVに対する内翻抜去と同様に行った。
As an inversion stripper for SSV, a bendable silver-plated copper rod having a diameter of 2 mm and a length of 27 mm is joined with a stainless wire having a diameter of 1.2 mm and a length of 45 cm. A vein ligation part is provided on the wire side. The stainless rod can be inserted into a vein and projected from the skin incised in the peripheral portion.
Also, a Babcock is attached to the end of the stainless wire.
A bell-shaped head (extraction head) can be attached so that it can be changed to the law. The inversion of the SSV was performed in the same manner as the inversion of the LSV of Example 1.

【0018】[0018]

【発明の効果】本発明の薬液注入針管によって、生体組
織内への薬液注入、特に静脈瘤抜去を行う内翻式ストリ
ッピング手術、特にLSVおよびSSVの内翻式ストリ
ッピング手術における、術中および術後の疼痛を軽減す
るための麻酔液、止血液等の薬液を効果的かつ簡単にL
SVおよびSSVに沿って、注入することができる。
INDUSTRIAL APPLICABILITY With the drug solution injection needle tube of the present invention, intraoperative stripping surgery for injecting a drug solution into a living tissue, particularly removing varicose veins, particularly intraoperative stripping surgery for LSV and SSV, is performed during and after surgery. Effective and easy administration of anesthesia solution, hemostasis and other medicinal solutions to reduce subsequent pain
Injection can be along the SV and SSV.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の針管全体が均一な曲率で湾曲した薬液
注入針管の概略図である。
FIG. 1 is a schematic view of a drug solution injection needle tube in which the entire needle tube of the present invention is curved with a uniform curvature.

【図2】針管を湾曲させない前の本発明の薬液注入針管
の概略図である。
FIG. 2 is a schematic view of the drug solution injection needle tube of the present invention before bending the needle tube.

【符号の説明】[Explanation of symbols]

1 丸みを帯びた先頭部 2 小孔 3 小孔 4 小孔 5 壁部 6 針基部 7 針管 8 雌ルアー 1 rounded top 2 small holes 3 small holes 4 small holes 5 walls 6 needle base 7 needle tubes 8 female lures

Claims (18)

【特許請求の範囲】[Claims] 【請求項1】 針管が湾曲形状にあらかじめ形成され、
少なくとも先端側部分に薬液注入用の小孔を有し、かつ
先端部が生体組織を穿刺しない丸みを帯びた構造である
ことを特徴とする薬液注入用針管。
1. A needle tube is preformed in a curved shape,
A drug solution injection needle tube characterized by having a small hole for injecting a drug solution at least at a tip side portion thereof, and having a rounded structure in which the tip part does not puncture a biological tissue.
【請求項2】 人手によって針管を湾曲形状に形成する
ことが可能な可撓性を有し、また、少なくとも先端側部
分に薬液注入用の小孔を有し、かつ先端部が生体組織を
穿刺しない丸みを帯びた構造であることを特徴とする薬
液注入用針管。
2. A flexible needle tube can be manually formed into a curved shape, a small hole for injecting a drug solution is provided at least at a tip side portion, and the tip portion punctures a biological tissue. A needle tube for injecting a drug solution, which has a rounded structure.
【請求項3】 針管全体が均一な曲率を有する湾曲形状
であることを特徴とする請求項1または2記載の薬液注
入用針管。
3. The drug solution injection needle tube according to claim 1, wherein the entire needle tube has a curved shape having a uniform curvature.
【請求項4】 曲率が、650〜850アール程度の曲
率半径であることを特徴とする請求項3記載の薬液注入
用針管。
4. The needle tube for injecting a drug solution according to claim 3, wherein the curvature has a radius of curvature of about 650 to 850 ares.
【請求項5】 前記湾曲形状は、針管の生体内への挿入
および移動によってもその湾曲形状を保持することので
きる剛性を有することを特徴とする請求項1〜4のいず
れかに記載の薬液注入用針管。
5. The drug solution according to claim 1, wherein the curved shape has rigidity such that the curved shape can be maintained even when the needle tube is inserted into the living body and moved. Needle tube for injection.
【請求項6】 前記小孔の数が1〜3個で、針管の側壁
に形成されていることを特徴とする請求項1〜5のいず
れかに記載の薬液注入用針管。
6. The drug solution injection needle tube according to claim 1, wherein the number of the small holes is 1 to 3, and the small holes are formed on a side wall of the needle tube.
【請求項7】 前記複数の小孔が、針管の対向する側壁
に交互に形成されたことを特徴とする請求項6記載の薬
液注入用針管。
7. The needle tube for injecting a chemical solution according to claim 6, wherein the plurality of small holes are alternately formed on the opposite side walls of the needle tube.
【請求項8】 前記小孔のすべてが先端部から35mm
以内に形成されていることを特徴とする請求項1〜7の
いずれかに記載の薬液注入用針管。
8. All of the small holes are 35 mm from the tip.
The needle tube for chemical injection according to any one of claims 1 to 7, wherein the needle tube is formed within the inside.
【請求項9】 針管先端部が小孔を有しない閉塞構造で
あることを特徴とする請求項1〜8のいずれかに記載の
薬液注入用針管。
9. The needle tube for injecting a drug solution according to claim 1, wherein the tip of the needle tube has a closed structure having no small hole.
【請求項10】 薬液注入用針管を構成する基材が銅材
料であることを特徴とする請求項1〜9のいずれかに記
載の薬液注入用針管。
10. The needle tube for chemical injection according to any one of claims 1 to 9, wherein the base material forming the needle tube for chemical injection is a copper material.
【請求項11】 薬液注入用針管の直径が、12〜18
ゲージで、湾曲部を形成する前の針管の長さが20cm
以上であることを特徴とする請求項1〜10のいずれか
に記載の薬液注入用針管。
11. The needle tube for injecting a drug solution has a diameter of 12-18.
With a gauge, the length of the needle tube before forming the curved portion is 20 cm
It is above, The needle tube for chemical | medical solution injection in any one of the Claims 1-10 characterized by the above-mentioned.
【請求項12】 薬液注入用針管の直径が、14〜16
ゲージである請求項11記載の薬液注入用針管。
12. The needle tube for injecting a drug solution has a diameter of 14 to 16
The drug solution injection needle tube according to claim 11, which is a gauge.
【請求項13】 大量局所浸潤麻酔(Tumescen
t Local Anesthesia:以下、TLA
ともいう)用に用いることを特徴とする請求項1〜12
のいずれかに記載の薬液注入用針管。
13. Mass local infiltration anesthesia (Tumescen)
t Local Anesthesia: TLA
It is also used for).
The needle tube for injecting a drug solution according to any one of 1.
【請求項14】 針基部分が、雄ルアーが接合可能に雌
ルアーが形成されていることを特徴とする請求項1〜1
3のいずれかに記載の薬液注入用針管。
14. The needle base portion is formed with a female luer so that a male luer can be joined thereto.
The needle tube for injecting a drug solution according to any one of 3 above.
【請求項15】 注射器に装着可能な請求項1〜14の
いずれかに記載の薬液注入用針管。
15. The needle tube for injecting a drug solution according to claim 1, which is attachable to a syringe.
【請求項16】 請求項15記載の薬液注入用針管を装
着した注射器。
16. A syringe equipped with the drug solution injection needle tube according to claim 15.
【請求項17】 LSVまたはSSVに対する静脈瘤除
去手術法に使用することを特徴とする請求項16記載の
注射器。
17. The syringe according to claim 16, which is used for varicose vein removal surgery for LSV or SSV.
【請求項18】 脂肪組織内の脂肪の吸引に使用するこ
とを特徴とする請求項16記載の注射器。
18. The syringe according to claim 16, which is used for suctioning fat in adipose tissue.
JP2001253880A 2001-08-24 2001-08-24 Needle tube for injecting medicinal solution and syringe equipped with the needle tube for injecting medicinal solution Expired - Lifetime JP4892800B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001253880A JP4892800B2 (en) 2001-08-24 2001-08-24 Needle tube for injecting medicinal solution and syringe equipped with the needle tube for injecting medicinal solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001253880A JP4892800B2 (en) 2001-08-24 2001-08-24 Needle tube for injecting medicinal solution and syringe equipped with the needle tube for injecting medicinal solution

Publications (2)

Publication Number Publication Date
JP2003062068A true JP2003062068A (en) 2003-03-04
JP4892800B2 JP4892800B2 (en) 2012-03-07

Family

ID=19082132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001253880A Expired - Lifetime JP4892800B2 (en) 2001-08-24 2001-08-24 Needle tube for injecting medicinal solution and syringe equipped with the needle tube for injecting medicinal solution

Country Status (1)

Country Link
JP (1) JP4892800B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006271651A (en) * 2005-03-29 2006-10-12 Matsumoto Shika Univ Needle component for liquid injection, and production method thereof
JP2010537900A (en) * 2007-08-30 2010-12-09 カルメル プハルマ アクチボラゲット Apparatus, sealing member, and fluid container
JP2011510715A (en) * 2008-02-04 2011-04-07 ハーツォグ,バーナード Hollow needle
JP2012020042A (en) * 2010-07-16 2012-02-02 Japan Imposing Co Ltd Hypodermic injection needle
US8672889B2 (en) 2006-05-05 2014-03-18 Kimberly-Clark Worldwide, Inc. Soft tissue tunneling device
CN104368066A (en) * 2014-11-28 2015-02-25 齐元富 Multi-angle tumor medicine injector
US9289232B2 (en) 2006-05-05 2016-03-22 Avent, Inc. Soft tissue tunneling device
US10398834B2 (en) 2007-08-30 2019-09-03 Carmel Pharma Ab Device, sealing member and fluid container

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436091A (en) * 1977-08-26 1979-03-16 Ims Ltd Laryngotracheal syringe
JPS62112568A (en) * 1985-11-06 1987-05-23 スミス インダストリ−ズ パブリツク リミテツド カンパニ− Catheter for administering fluid to local part of human body
WO2001028473A1 (en) * 1999-10-21 2001-04-26 Alcon Universal Ltd. Sub-tenon drug delivery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436091A (en) * 1977-08-26 1979-03-16 Ims Ltd Laryngotracheal syringe
JPS62112568A (en) * 1985-11-06 1987-05-23 スミス インダストリ−ズ パブリツク リミテツド カンパニ− Catheter for administering fluid to local part of human body
WO2001028473A1 (en) * 1999-10-21 2001-04-26 Alcon Universal Ltd. Sub-tenon drug delivery

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006271651A (en) * 2005-03-29 2006-10-12 Matsumoto Shika Univ Needle component for liquid injection, and production method thereof
US8672889B2 (en) 2006-05-05 2014-03-18 Kimberly-Clark Worldwide, Inc. Soft tissue tunneling device
US9289232B2 (en) 2006-05-05 2016-03-22 Avent, Inc. Soft tissue tunneling device
JP2010537900A (en) * 2007-08-30 2010-12-09 カルメル プハルマ アクチボラゲット Apparatus, sealing member, and fluid container
US10398834B2 (en) 2007-08-30 2019-09-03 Carmel Pharma Ab Device, sealing member and fluid container
US11071818B2 (en) 2007-08-30 2021-07-27 Carmel Pharma Ab Device, sealing member and fluid container
JP2011510715A (en) * 2008-02-04 2011-04-07 ハーツォグ,バーナード Hollow needle
JP2012020042A (en) * 2010-07-16 2012-02-02 Japan Imposing Co Ltd Hypodermic injection needle
CN104368066A (en) * 2014-11-28 2015-02-25 齐元富 Multi-angle tumor medicine injector

Also Published As

Publication number Publication date
JP4892800B2 (en) 2012-03-07

Similar Documents

Publication Publication Date Title
US5836945A (en) Biological vessel harvesting device
US7588557B2 (en) Medical instrument for fluid injection and related method
US8197478B2 (en) Apparatus and method for electrically induced thrombosis
US20120016203A1 (en) Methods and systems for minimally invasive endoscopic surgeries
US20070135791A1 (en) Method for Infusing the Interior of a Blood Vessel
US5970982A (en) Minimally invasive biological vessel harvesting method
Fujishiro et al. Management of bleeding concerning endoscopic submucosal dissection with the flex knife for stomach neoplasm
CN104490455A (en) Disposable circumcision anastomat
Jou et al. Nephrostomy tube-free percutaneous nephrolithotomy for patients with large stones and staghorn stones
JP4892800B2 (en) Needle tube for injecting medicinal solution and syringe equipped with the needle tube for injecting medicinal solution
US7931029B2 (en) Method and apparatus for uterus stabilization
US20040215226A1 (en) Harvester
JPWO2004021891A1 (en) Stripping wire and stripping catheter for removing veins
WO2003000143A1 (en) Great saphenous vein varix treatment tool
RU2400261C1 (en) Method of catheter scleroobliteration of main subcutaneous veins of lower extremities
RU2536558C1 (en) Method of treating postpunctional pulsatile haematoma
RU2371114C1 (en) Adenomectomy technique
RU2164089C2 (en) Method for catheterizing the right gastroepiploic artery
Perrault et al. Techniques, complications, and pitfalls of endoscopic saphenectomy for coronary artery bypass grafting surgery
RU2326708C1 (en) Method of pelvic limb reticular varix and telangiectasia treatment
RU2797099C1 (en) Method of local anesthesia of the median laparotomic wound using semi-permeable membranes.
RU2258480C1 (en) Method for nontypical endoscopic papillotomy
Haruta et al. Technical procedure of two-port system subfascial endoscopic perforator vein surgery (TPS-SEPS)
Hilton et al. Operations on the vulva
RU2140218C1 (en) Method of recovery of permeability of obliterated rear urethra

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080513

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100716

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100727

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100924

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100924

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110315

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110514

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111122

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111205

R150 Certificate of patent or registration of utility model

Ref document number: 4892800

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150106

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term